ARWR
Arrowhead Pharmaceuticals, Inc.
$71.91
-2.20 (-2.97%)
At close · Jul 14
Market Cap
$10.13B
Shares
140,857,021
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
51/100
Short interest 6.0% of shares — P78
Days to cover 2.2 — P48
Price vs VWAP -5.8% — P36
Short-volume trend -0.4% — P50
Short interest change -28.2% — P12
Worst FTD 0.01% of shares — P45
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 8,430,780 | 11,738,844 | -3,308,064 | 2.21 |
| 2026-06-15 | 11,738,844 | 12,391,532 | -652,688 | 8.18 |
| 2026-05-29 | 12,391,532 | 12,925,632 | -534,100 | 8.30 |
| 2026-05-15 | 12,925,632 | 12,939,446 | -13,814 | 7.01 |
| 2026-04-30 | 12,939,446 | 12,012,359 | +927,087 | 6.74 |
| 2026-04-15 | 12,012,359 | 13,004,381 | -992,022 | 7.66 |
| 2026-03-31 | 13,004,381 | 11,428,679 | +1,575,702 | 5.35 |
| 2026-03-13 | 11,428,679 | 11,141,896 | +286,783 | 4.31 |
| 2026-02-27 | 11,141,896 | 10,818,896 | +323,000 | 5.92 |
| 2026-02-13 | 10,818,896 | 11,150,281 | -331,385 | 2.15 |
| 2026-01-30 | 11,150,281 | 10,790,834 | +359,447 | 5.68 |
| 2026-01-15 | 10,790,834 | 9,626,302 | +1,164,532 | 3.00 |
| 2025-12-31 | 9,626,302 | 10,234,550 | -608,248 | 5.33 |
| 2025-12-15 | 10,234,550 | 11,836,793 | -1,602,243 | 2.95 |
| 2025-11-28 | 11,836,793 | 11,596,104 | +240,689 | 3.44 |
| 2025-11-14 | 11,596,104 | 11,784,510 | -188,406 | 7.11 |
| 2025-10-31 | 11,784,510 | 11,648,427 | +136,083 | 6.82 |
| 2025-10-15 | 11,648,427 | 11,698,624 | -50,197 | 6.34 |
| 2025-09-30 | 11,698,624 | 11,862,693 | -164,069 | 4.77 |
| 2025-09-15 | 11,862,693 | 12,729,088 | -866,395 | 3.55 |
| 2025-08-29 | 12,729,088 | 12,984,322 | -255,234 | 5.56 |
| 2025-08-15 | 12,984,322 | 12,937,337 | +46,985 | 5.19 |
| 2025-07-31 | 12,937,337 | 12,418,563 | +518,774 | 5.46 |
| 2025-07-15 | 12,418,563 | 12,616,251 | -197,688 | 7.92 |
Showing 1–24 of 24 settlements
Key facts
CIK
879407
CUSIP
04280A100
13F (30d)
32 filings
27 filers
Visit website
Investor relations